![Hirofusa Shirai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hirofusa Shirai
Voorzitter bij ASAMA Research Extension Center
Oorsprong van het eerstegraads netwerk van Hirofusa Shirai
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Shinshu University
5
| College/University | Other Consumer Services | 5 |
Public Company | Pharmaceuticals: Other | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hirofusa Shirai via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
THE HACHIJUNI BANK, LTD. | Regional Banks | Director/Board Member | |
TAIHO KOGYO CO., LTD. | Auto Parts: OEM | Director/Board Member | |
CAR MATE MFG. CO., LTD. | Auto Parts: OEM | Director/Board Member | |
Teikyo University | College/University | Corporate Officer/Principal | |
The Museum of Modern Art
![]() The Museum of Modern Art Other Consumer ServicesConsumer Services The Museum of Modern Art exhibits modern and contemporary art. The organization was founded by Alfred H. Barr in 1929 and is located in New York, NY. | Other Consumer Services | Director/Board Member | |
Kyushu University | College/University | Doctorate Degree | |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Biotechnology | Founder | |
GLOSEL CO., LTD. | Electronic Components | Director/Board Member | |
Mebiopharm Co., Ltd.
![]() Mebiopharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Mebiopharm Co., Ltd. engages in the pharmaceutical business. Its services include drug development, commercialization of acquired patents, and outsourcing pre-clinical and clinical trials. The company was founded by Tadashi Fujisawa, Masazumi Eriguchi, Hironobu Yanagie and Kazuo Maruyama on July 15, 2002 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
Japan | 9 |
Verenigde Staten | 2 |
Sectoraal
Consumer Services | 4 |
Producer Manufacturing | 3 |
Health Technology | 3 |
Finance | 2 |
Electronic Technology | 2 |
Operationeel
Director/Board Member | 12 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 6 |
Founder | 2 |
Doctorate Degree | 1 |
Sterkste connecties
- Beurs
- Insiders
- Hirofusa Shirai
- Bedrijfsconnecties